To study the effect of MIF on the proliferation of BPH epithelial cells in vitro, recombinant human MIF (rMIF) and MIF inhibitor ISO-1 were used to treat BPH-1 and PWR-1E cells. Here, MIF is linked to benign prostatic hyperplasia.